FDA advisory panel votes to reformulate COVID-19 boosters to target Omicron...

UPI | 2022-06-29 00:26 UTC

An FDA advisory panel voted 19-2 to reformulate COVID-19 booster vaccines this fall to target Omicron's BA.4 and BA.5 subvariants, which account for half of all COVID cases in the United States, according to the CDC.

By Anonymous Submission on 2022-06-29 14:54 UTC
  • Need an account?